Edgen Stock·Dec 12 2025, 17:33Back
Biogen Drug News Challenges Revenue Slump
Edgen Stock·Dec 12 2025, 17:33
[1] Canadian HTA Assessments Recognize Therapeutic Value of QALSODY™ (tofersen injection) and its Potential to Modify Disease Progression in Individuals Living with SOD1-ALS - BioSpace (https://www.biospace.com/press-releases/canad ...)[2] Pfizer (PFE) Stock Outlook After the November 21 FDA Win: Obesity Deals, Cost Cuts and a 6.7% Dividend Yield - ts2.tech (https://ts2.tech/en/pfizer-pfe-stock-outlook- ...)[3] Procter & Gamble (PG) Stock Outlook: Dividend King Near Two‑Year Lows as Wall Street Weighs Tariffs, Jobs Cuts and 2026 Growth - ts2.tech (https://ts2.tech/en/procter-gamble-pg-stock-o ...)
